Recent Articles By The Author
Biotech Movers: Neurocrine Biosciences Leaps on Drug Approval, Synergy Pharma Issued Three Patents
The company's shares were up 24% ahead of market's open on an FDA approval.
Mylan Falls on FDA Warning on Quality Control
The EpiPen-maker has received a letter from the FDA about its manufacturing facility in Nashik, India.
Medivation Founder Takes Helm at Axovant, Shares Spike
David Hung will become Axovant's CEO after completing the $14 billion sale of Medivation to Pfizer.
Endo international, AngioDynamics Lead Biotech Movers
Endo International slipped 5% ahead of market's open Friday.